He added that he would not be surprised if coronavirus cases increase over the next couple of weeks.
CARMAT, the developer of the world’s most advanced completely artificial heart has successfully raised €40.5 million in funding. The raise is set to finance the production of their Aeson artificial heart, which the company hopes will provide an alternative treatment option for people with heart failure – a condition affecting around 6.2 million adults in the US alone [1].
Longevity. Technology: Beating around 100,000 times per day, your heart works around the clock to keep your circulatory system ticking. The steady sound of your heartbeat is a comforting constant throughout your life. Forming the centre of the circulatory system, the heart continuously pumps blood around the body to deliver oxygen and nutrients to cells. Due to this constant work, our hearts can unfortunately wear out as we age, with cardiovascular diseases continuing to be the leading causes of death globally [2].
End-stage heart failure is a serious condition that occurs when the heart can no longer transport blood throughout the body effectively. It most often affects the left chamber of the heart, which pumps oxygen-rich blood around the body, leading to biventricular heart failure. Vital organs like the brain, liver and kidney fail to get enough oxygen and nutrients to function properly. With few treatment options, end-stage heart failure sometimes requires serious intervention like heart transplantation – considered the gold standard therapy. However, due to the global shortage in organ donors, this is not always possible and there is a gap for a therapeutic alternative that could have huge implications for longevity globally.
This kind of data can help uncover how the structure and organization of the brain give rise to behavior, emotion and cognition, in sickness and in health.
Learn More.
The Neuro-Network.
NEW YORK – A collaboration between researchers at Columbia and the Icahn School of Medicine is embarking on a project that will generate comprehensive atlases of entire human brains and all their 180+ billion cells. This kind of data can help uncover how the structure and organization of the brain give rise to behavior, emotion and cognition, in sickness and in health.
Credit: Hillman Lab/Columbia’s Zuckerman Institute.
Obesity and its consequences on overall health have become a serious global problem. However, very few substances or drugs can fight obesity. In a recent study, Japanese researchers investigated the anti-obesity effects of tocotrienols, a subtype of vitamin E. Experiments showed that tocotrienols significantly reduce the weight gained by mice on a high-fat diet, while also lowering “bad” cholesterol levels. The results pave the way to efficient treatments for obesity.
Over the past few decades, obesity has become increasingly common throughout the entire world. Since obesity often causes other diseases, including diabetes and various cardiovascular disorders, it represents an alarming social problem in both developed and developing countries. Although most of us know that a balanced diet and plenty of exercise are the best ways to prevent obesity, having drugs to effectively treat it would still come in handy if necessary.
Unfortunately, there are very few known substances or drugs that can help prevent or treat obesity and its dreaded secondary diseases. One problem is that some of the mechanisms of obesity-induced diseases are unclear. For example, there is some evidence showing that obesity increases oxidative stress (oxidation) in the body. In turn, some scientists suspect that increased oxidation is the reason why obesity paves the way for neurodegenerative disorders like Alzheimer’s disease. Taking this into account, it might be helpful if potential drugs for treating obesity also had strong antioxidant functions.
The pancreas is a key metabolic regulator. When pancreatic beta cells cease producing enough insulin, blood sugar levels rise dangerously — a phenomenon known as hyperglycemia — thus triggering diabetes. After discovering that other mature pancreatic cells can adapt and partly compensate for the lack of insulin, a team from the University of Geneva (UNIGE) demonstrates that the stem cells from which beta cells are derived are only present during embryonic development. This discovery puts an end to a long-standing controversy about the hypothetical existence of adult pancreatic stem cells that would give rise to newly differentiated hormone-producing cells after birth. The scientists also succeeded in precisely defining the ‘identity card’ of pancreatic endocrine cells, which is a promising tool for the production of replacement insulin-secreting cells. These results can be read in Cell Reports and Nature Communications.
Diabetes is a common metabolic disease. It is characterised by a persistent hyperglycemia that occurs when pancreatic cells responsible for the production of insulin — the beta cells — are destroyed or are no longer able to produce this regulatory hormone in sufficient quantities. Since 2010, studies performed by the team of Pedro Herrera, a professor in the Department of Genetic Medicine and Development and in the Diabetes Centre at the UNIGE Faculty of Medicine, as well as at the Geneva Institute of Genetics and Genomics (iGE3), reveal that the other pancreatic endocrine cells — namely alpha, delta and gamma cells, which produce other hormones useful for the metabolic balance — can “learn” to produce insulin when beta cells are absent or defective. This phenomenon, observed in mice and humans, demonstrates the plasticity of pancreatic cells and paves the way to new therapeutic strategies.
Design also poised to save space, retain memory in event of power loss. A new spin on one of the 20th century’s smallest but grandest inventions, the transistor, could help feed the world’s ever-growing appetite for digital memory while slicing up to 5% of the energy from its power-hungry diet.
And if bacteria causes one kind, whos to say it doesnt cause every other kind.
Genetic information on the microbes has already allowed the scientists to piece together how they may behave in the body, including what toxins and other substances they might release. This has led them to develop half a dozen hypotheses around how the bugs could cause prostate cancer.
“We currently have no way of reliably identifying aggressive prostate cancers, and this research could help make sure men get the right treatment for them,” Luxton added.
“If the team can demonstrate that these newly identified bacteria can not only predict, but actually cause aggressive prostate cancer, for the first time we may actually be able to prevent prostate cancer occurring. This would be a huge breakthrough that could save thousands of lives each year.”
Materials scientists aim to develop biomimetic soft robotic crawlers including earthworm-like and inchworm-like crawlers to realize locomotion via in-plane and out-of-plane contractions for a variety of engineering applications. While such devices can show effective motion in confined spaces, it is challenging to miniaturize the concept due to complex and limited actuation. In a new report now published in Science Advances, Qiji Ze and a team of scientists in mechanical engineering and aerospace engineering at Stanford University and the Ohio State University, U.S., described a magnetically actuated, small-scale origami crawler exhibiting in-plane contraction. The team achieved contraction mechanisms via a four-unit Kresling origami assembly to facilitate the motion of an untethered robot with crawling or steering capacity. The crawler overcame large resistances in severely confined spaces due to its magnetically tunable structural stiffness and anisotropy. The setup provided a contraption for drug storage and release with potential to serve as a minimally invasive device in biomedicine.
Navigating complicated terrains
Bioinspired crawling motion shows adaptation to complicated terrains due to its soft deformable dimensions. Researchers aim to engineer crawling for a variety of applications in limited or confined environments, including extraterrestrial exploration, tube inspection, and gastrointestinal endoscopy. Origami provides an appropriate method to generate contraction relative to structural folding, which can be adapted to engineer robotic crawlers. The team described Kresling patterns; a specific type of bioinspired, origami pattern used to generate axial contraction under torque or compressive force, coupled with a twist from the relative rotation of the device units. Ze et al illustrated a magnetically actuated small-scale origami crawler to induce effective in-plane crawling motions. The scientists developed a four-unit Kresling assembly and verified torque distribution on the crawler using finite element analysis to induce motion.